Compounds > cilostazol

cilostazol and angiotensin ii

cilostazol has been researched along with angiotensin ii in 7 studies

Research

Studies (7)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (28.57)29.6817
2010's4 (57.14)24.3611
2020's1 (14.29)2.80

Authors

AuthorsStudies
Jin, D; Kirimura, K; Miyazaki, M; Nishimoto, M; Sakaguchi, M; Takai, S; Yuda, A1
Cho, WH; Choi, HS; Hur, SH; Jung, GS; Kim, BW; Kim, HS; Kim, HT; Kim, JG; Kim, MK; Lee, HJ; Lee, IK; Lee, KM; Lee, KU; Lim, JO; Park, KG1
Ariyoshi, M; Hirano, K; Hirano, M; Inoue, R; Iwamoto, T; Jian, Z; Kita, S; Kurose, H; Nakaya, M; Nishida, M; Nishioka, K; Saiki, S; Sato, Y1
Feng, ZC; Li, X; Lian, C; Liu, XT; Shi, MQ; Su, FF; Wang, HT; Xu, X; Zhang, W; Zheng, QS1
Daugherty, A; Kakio, Y; Subramanian, V; Uchida, HA; Umebayashi, R; Wada, J1
Agarwal, H; Barthwal, MK; Reddy, SS1
Hada, Y; Uchida, HA; Umebayashi, R; Wada, J; Yoshida, M1

Other Studies

7 other study(ies) available for cilostazol and angiotensin ii

ArticleYear
Cilostazol suppresses intimal formation in dog grafted veins with reduction of angiotensin II-forming enzymes.
    European journal of pharmacology, 2001, Jan-12, Volume: 411, Issue:3

    Topics: Angiotensin II; Animals; Blood Vessels; Chymases; Cilostazol; Dogs; In Vitro Techniques; Neovascularization, Pathologic; Peptidyl-Dipeptidase A; Serine Endopeptidases; Tetrazoles; Vasodilator Agents

2001
Cilostazol inhibits high glucose- and angiotensin II-induced type 1 plasminogen activator inhibitor expression in artery wall and neointimal region after vascular injury.
    Atherosclerosis, 2009, Volume: 207, Issue:2

    Topics: Angioplasty, Balloon; Angiotensin II; Animals; Binding Sites; Blood Glucose; Carotid Arteries; Carotid Artery Injuries; Cell Proliferation; Cells, Cultured; Cilostazol; Diabetes Mellitus, Experimental; Dose-Response Relationship, Drug; Fibrinolytic Agents; Hyperplasia; JNK Mitogen-Activated Protein Kinases; Male; Muscle, Smooth, Vascular; p38 Mitogen-Activated Protein Kinases; Phosphodiesterase Inhibitors; Plasminogen Activator Inhibitor 1; Promoter Regions, Genetic; Rats; Rats, Sprague-Dawley; Signal Transduction; Smad3 Protein; Tetrazoles; Transcriptional Activation; Transforming Growth Factor beta; Tunica Intima

2009
Cilostazol suppresses angiotensin II-induced vasoconstriction via protein kinase A-mediated phosphorylation of the transient receptor potential canonical 6 channel.
    Arteriosclerosis, thrombosis, and vascular biology, 2011, Volume: 31, Issue:10

    Topics: Angiotensin II; Animals; Aorta, Thoracic; Calcium Signaling; Cilostazol; Cyclic AMP-Dependent Protein Kinases; Diglycerides; Dose-Response Relationship, Drug; HEK293 Cells; Humans; Male; Mice; Muscle, Smooth, Vascular; Mutation; Myocytes, Smooth Muscle; Phosphodiesterase 3 Inhibitors; Phosphorylation; Protein Processing, Post-Translational; Rats; Rats, Sprague-Dawley; rho GTP-Binding Proteins; Tetrazoles; Transfection; TRPC Cation Channels; TRPC6 Cation Channel; Vasoconstriction; Vasoconstrictor Agents; Vasodilator Agents

2011
Cilostazol suppresses angiotensin II-induced apoptosis in endothelial cells.
    Molecular medicine reports, 2016, Volume: 13, Issue:3

    Topics: Angiotensin II; Animals; Apoptosis; Blood Pressure; Cilostazol; Human Umbilical Vein Endothelial Cells; Male; Nitrous Oxide; Phosphodiesterase 3 Inhibitors; Rats; Superoxides; Tetrazoles

2016
Cilostazol Attenuates Angiotensin II-Induced Abdominal Aortic Aneurysms but Not Atherosclerosis in Apolipoprotein E-Deficient Mice.
    Arteriosclerosis, thrombosis, and vascular biology, 2018, Volume: 38, Issue:4

    Topics: Angiotensin II; Animals; Anti-Inflammatory Agents; Aorta, Abdominal; Aortic Aneurysm, Abdominal; Atherosclerosis; Cell Adhesion Molecules; Cells, Cultured; Cilostazol; Cyclic AMP; Cyclic AMP-Dependent Protein Kinases; Cytokines; Dilatation, Pathologic; Disease Models, Animal; Endothelial Cells; Male; Mice, Knockout, ApoE; Phosphodiesterase 3 Inhibitors; Signal Transduction

2018
Cilostazol ameliorates heart failure with preserved ejection fraction and diastolic dysfunction in obese and non-obese hypertensive mice.
    Journal of molecular and cellular cardiology, 2018, Volume: 123

    Topics: Angiotensin II; Animals; Biomarkers; Biopsy; Blood Pressure; Cilostazol; Diastole; Disease Models, Animal; Disease Progression; Echocardiography; Energy Metabolism; Fibrosis; Heart Failure; Hypertension; Immunohistochemistry; Male; Mice; Renin; Stroke Volume; Vasodilator Agents; Ventricular Dysfunction, Left

2018
Cilostazol Attenuates AngII-Induced Cardiac Fibrosis in apoE Deficient Mice.
    International journal of molecular sciences, 2022, Aug-13, Volume: 23, Issue:16

    Topics: Angiotensin II; Animals; Cilostazol; Fibrosis; Humans; Male; Mice; Mice, Inbred C57BL; Mice, Knockout, ApoE; Myocardium; Osteopontin; RNA, Messenger

2022